Lack of consideration of sex and gender in COVID-19 clinical studies
Sex and gender have been associated with differences in SARS-CoV-2 incidence and clinical outcomes and therefore warrant consideration in study designs. Here, the authors assess registered and published clinical COVID-19 studies and find that sex-disaggregated analyses are infrequently presented or...
Enregistré dans:
Auteurs principaux: | Emer Brady, Mathias Wullum Nielsen, Jens Peter Andersen, Sabine Oertelt-Prigione |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/39d0857df4b3423d9208ab831e65a72c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Coronavirus Disease 2019 Outbreak Highlights the Importance of Sex-sensitive Medicine
par: Angela HEM Maas, et autres
Publié: (2020) -
Sex and Gender Bias in Covid-19 Clinical Case Reports
par: Aysha E. Salter-Volz, et autres
Publié: (2021) -
A Systematic Review of the Sex and Gender Reporting in COVID-19 Clinical Trials
par: Shirin Heidari, et autres
Publié: (2021) -
Sex and gender considerations in reporting guidelines for health research: a systematic review
par: Amédé Gogovor, et autres
Publié: (2021) -
Ethical considerations for clinicians faced with patients lacking the capacity to form reasoned judgments regarding COVID-19 tests and isolation
par: Jeffrey Yuk Chiu Yip
Publié: (2021)